Skip to main content

Biomarin Pharmaceuticals (NQ: BMRN )

88.61 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2024 Add to My Watchlist

Other Filings

Form S-8
Source: SEC/Edgar
May 14, 2013
Form 8-K
Source: SEC/Edgar
April 24, 2013
Form ARS
Source: SEC/Edgar
April 07, 2013
Form DEF 14A
Source: SEC/Edgar
April 04, 2013
Form DEFA14A
Source: SEC/Edgar
April 04, 2013
Form CT ORDER
Source: SEC/Edgar
April 01, 2013
Form 8-K
Source: SEC/Edgar
March 26, 2013
Form 8-K
Source: SEC/Edgar
March 17, 2013
Form 8-K
Source: SEC/Edgar
March 17, 2013
Form 8-K
Source: SEC/Edgar
February 20, 2013
Form SC 13G/A
Source: SEC/Edgar
February 13, 2013
Form SC 13G/A
Source: SEC/Edgar
February 13, 2013
Form SC 13G/A
Source: SEC/Edgar
February 13, 2013
Form SC 13G
Source: SEC/Edgar
February 12, 2013
Form SC 13G/A
Source: SEC/Edgar
February 11, 2013
Form 8-K
Source: SEC/Edgar
December 17, 2012
Form SC 13G/A
Source: SEC/Edgar
December 10, 2012
Form 8-K
Source: SEC/Edgar
November 27, 2012
Form SC 13G
Source: SEC/Edgar
November 04, 2012
Form 8-K
Source: SEC/Edgar
October 24, 2012
Form CT ORDER
Source: SEC/Edgar
September 13, 2012
Form 8-K
Source: SEC/Edgar
September 04, 2012
Form 8-K
Source: SEC/Edgar
July 31, 2012
Form 424B5
Source: SEC/Edgar
May 31, 2012
Form 8-K
Source: SEC/Edgar
May 31, 2012
Form 8-K
Source: SEC/Edgar
May 30, 2012
Form 8-A12G/A
Source: SEC/Edgar
May 29, 2012
Form S-3ASR
Source: SEC/Edgar
May 29, 2012
Form 424B5
Source: SEC/Edgar
May 29, 2012
Form S-8 POS
Source: SEC/Edgar
May 28, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.